Provention Bio shares tumble as U.S. FDA declines to approve diabetes drug
By Amruta Khandekar (Reuters) -The U.S. health regulator on Tuesday declined to approve Provention Bio
By Amruta Khandekar (Reuters) -The U.S. health regulator on Tuesday declined to approve Provention Bio
Posted: Jul 1, 2021 / 10:00 AM CDT / Updated: Jun 29, 2021 / 12:04
Kids’ hospitalization rates for new Type 2 diabetes more than doubled amid the coronavirus pandemic,
Rates and severity of Type 2 diabetes among U.S. children rose during the COVID-19 pandemic,
Syracuse, N.Y. – St. Joseph’s Health is prescribing a new type of medicine for patients
Diabetes has been described as a silent epidemic. Last year, it killed three times as
Credit: Unsplash/CC0 Public Domain In Finland, every fifth mother was diagnosed with gestational diabetes in
Santa Barbara – South County SANTA BARBARA COUNTY, Calif. — Sansum Diabetes Research Institute will
To illustrate the wonders of human physiology, Stanford University endocrinologist Sun Kim, MD, MS, occasionally
Credit: CC0 Public Domain A new study finds people who consume two servings of fruit